Detailed Sub-study Analysis of the SECRAB Trial: Quality of Life, Cosmesis and Chemotherapy Dose Intensity

AIMS: SECRAB was a prospective, open-label, multicentre, randomised phase III trial comparing synchronous to sequential chemoradiotherapy (CRT). Conducted in 48 UK centres, it recruited 2297 patients (1150 synchronous and 1146 sequential) between 2 July 1998 and 25 March 2004. SECRAB reported a posi...

Descripción completa

Detalles Bibliográficos
Autores principales: Fernando, I.N., Lax, S., Bowden, S.J., Ahmed, I., Steven, J.H., Churn, M., Brunt, A.M., Agrawal, R.K., Canney, P., Stevens, A., Rea, D.W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: W.B. Saunders 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10186116/
https://www.ncbi.nlm.nih.gov/pubmed/37012180
http://dx.doi.org/10.1016/j.clon.2023.03.007

Ejemplares similares

Ejemplares similares